Literature DB >> 7650805

Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion.

L S Tokgozoglu1, T Ashizawa, A Pacifico, R M Armstrong, H F Epstein, W A Zoghbi.   

Abstract

OBJECTIVE: To evaluate and quantitate cardiac involvement in myotonic dystrophy and assess whether the size of the trinucleotide (cytosine-thymine-guanine [CTG]) repeat expansion is a significant predictor of cardiac abnormalities.
DESIGN: Case-control study of a large kindred with myotonic dystrophy. PATIENTS: Ninety-one bloodline members of the kindred underwent clinical and cardiac evaluation with electrocardiograms, echocardiography (with Doppler in the majority of cases), and genetic and neurologic evaluations. Affected individuals were age-matched to normal family members. MAIN OUTCOME MEASURES: Electrocardiographic conduction abnormalities, wall motion abnormalities, mitral valve prolapse, and global parameters of systolic and diastolic function were determined by an observer blinded to all clinical data and genetic analysis.
RESULTS: Compared with age-matched normals, patients with myotonic dystrophy (n = 25) were more likely to have conduction abnormality (52% vs 9%), mitral valve prolapse (32% vs 9%), and wall motion abnormality (28% vs 0%) (all P < .05). Left ventricular ejection fraction and stroke volume were reduced compared with normals matched for age and heart rate (P < .05), whereas Doppler indexes of diastolic function were only marginally altered. Using multivariate analysis, the number of CTG repeats (range, 69 to 1367; normal, < or = 37) was the strongest predictor of abnormalities in wall motion and electrocardiographic conduction (odds ratio of 16.5 and 5.07 per 500 repeats, respectively). The relation of mitral valve prolapse to the size of the CTG repeat was of borderline significance. Patients with more extensive neurologic findings (n = 12) had a higher incidence of wall motion and/or electrocardiographic conduction abnormalities (83% vs 43%; P = .04).
CONCLUSIONS: Cardiac involvement in myotonic dystrophy affects predominantly the conduction system and myocardial function. Alterations in myocardial relaxation and diastolic properties, in contrast to skeletal muscle myotonia, are minor. In this kindred, the number of CTG repeats was a significant predictor of cardiac dysfunction in myotonic dystrophy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650805

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

1.  Female patient with proximal myotonic myopathy and ventricular tachycardia.

Authors:  S Schenk; S Löscher; F Mickley; A Hartmann
Journal:  Z Kardiol       Date:  2005-11

2.  Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy.

Authors:  Chaitali Misra; Sushant Bangru; Feikai Lin; Kin Lam; Sara N Koenig; Ellen R Lubbers; Jamila Hedhli; Nathaniel P Murphy; Darren J Parker; Lawrence W Dobrucki; Thomas A Cooper; Emad Tajkhorshid; Peter J Mohler; Auinash Kalsotra
Journal:  Dev Cell       Date:  2020-02-27       Impact factor: 12.270

3.  Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

Authors:  N R Clarke; A D Kelion; J Nixon; D Hilton-Jones; J C Forfar
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

4.  Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging.

Authors:  Evrim B Turkbey; Neville Gai; João A C Lima; Rob J van der Geest; Kathryn R Wagner; Gordon F Tomaselli; David A Bluemke; Saman Nazarian
Journal:  Heart Rhythm       Date:  2012-06-16       Impact factor: 6.343

5.  Pacing for conduction disturbances in Steinert's disease: a new indication for biventricular ICD?

Authors:  S A M Said; J C Baart; W G de Voogt
Journal:  Neth Heart J       Date:  2006-08       Impact factor: 2.380

6.  Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.

Authors:  Saman Nazarian; Kathryn R Wagner; Brian S Caffo; Gordon F Tomaselli
Journal:  Pacing Clin Electrophysiol       Date:  2010-10-14       Impact factor: 1.976

7.  Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.

Authors:  Misha Koshelev; Satyam Sarma; Roger E Price; Xander H T Wehrens; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2010-01-05       Impact factor: 6.150

8.  Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.

Authors:  Guey-Shin Wang; Debra L Kearney; Mariella De Biasi; George Taffet; Thomas A Cooper
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene.

Authors:  Hiroko Wakimoto; Colin T Maguire; Megan C Sherwood; Marcel M Vargas; Partha S Sarkar; Jennifer Han; Sita Reddy; Charles I Berul
Journal:  J Interv Card Electrophysiol       Date:  2002-10       Impact factor: 1.900

10.  Structural myocardial involvement in adult patients with type 1 myotonic dystrophy.

Authors:  Upinder K Dhand; Faisal Raja; Kul Aggarwal
Journal:  Neurol Int       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.